{"hands_on_practices": [{"introduction": "A hallmark of whooping cough is a persistent, paroxysmal cough that can last for weeks, even after antibiotic treatment has been initiated. This exercise [@problem_id:4614436] delves into the underlying mechanism for this phenomenon by comparing the rapid timescale of bacterial clearance with the much slower timescale of host tissue repair. By modeling these competing processes, you will gain a quantitative understanding of why the rate of epithelial regeneration, rather than pathogen elimination, becomes the rate-limiting step for symptom resolution.", "problem": "A patient presents with paroxysmal cough consistent with whooping cough caused by Bordetella pertussis. Consider the following mechanistic facts and a simplified quantitative model grounded in core biological principles. Fundamental bases: (i) the Central Dogma of Molecular Biology (DNA → RNA → protein) underlies host cell repair, which proceeds at finite rates determined by epithelial cell proliferation and differentiation; (ii) antibiotics directly reduce bacterial population but do not enzymatically reverse covalent toxin modifications or regenerate damaged host tissue; (iii) the mucociliary escalator clears airway secretions when ciliated epithelial cells are intact and beating effectively.\n\nKey, well-tested observations in Bordetella pertussis infection: tracheal cytotoxin kills ciliated epithelial cells; pertussis toxin (an AB toxin) ADP-ribosylates inhibitory G proteins, dysregulating signaling; adenylate cyclase toxin increases cyclic adenosine monophosphate, impairing phagocyte functions. These toxins cause sustained dysfunction even after bacterial numbers fall, until the airway epithelium regenerates.\n\nModel assumptions and parameters:\n- After initiation of appropriate antibiotic therapy at time $t_a$ (late paroxysmal phase), bacterial load $B(t)$ declines approximately exponentially as $B(t) = B_0 e^{-k_{ab}(t - t_a)}$ for $t \\geq t_a$, with $k_{ab} = 1 \\ \\text{day}^{-1}$.\n- Effective cilia density $D(t)$, a proxy for the proportion of functional ciliated epithelial cells, has been driven down by toxin exposure to $D_{\\min}$ by time $t_d$ and subsequently regenerates as $D(t) = D_{\\infty} - \\left(D_{\\infty} - D_{\\min}\\right) e^{-r_e (t - t_d)}$ for $t \\geq t_d$, with $r_e = 0.05 \\ \\text{day}^{-1}$, $D_{\\min}/D_{\\infty} = 0.3$.\n- Mucociliary clearance effectiveness $M(t)$ is proportional to the product of ciliary beat frequency and cilia density, so symptom resolution occurs when $D(t)$ crosses a threshold $D_{\\text{th}}$ corresponding to adequate clearance, here $D_{\\text{th}}/D_{\\infty} = 0.6$.\n\nUsing these premises, reason from first principles to decide which statement best explains why initiating antibiotic therapy late in the paroxysmal phase has limited impact on the duration of cough. Choose the single best option.\n\nA. Once significant toxin-mediated epithelial damage has occurred, the rate-limiting step for symptom resolution is epithelial regeneration of ciliated cells, which proceeds on a timescale set by $r_e$ and is largely independent of how quickly antibiotics clear bacteria; therefore late antibiotic therapy minimally shortens cough duration.\n\nB. Late antibiotic therapy prolongs cough because it inhibits development of protective immunological memory, delaying class-switching to immunoglobulin G in serum and thereby worsening mucociliary clearance independent of epithelial damage.\n\nC. Antibiotics rapidly neutralize pertussis toxins in the airway, immediately reversing covalent modifications of host proteins and restoring ciliary function, so late therapy always substantially shortens cough duration.\n\nD. Bordetella pertussis persists primarily as an intracellular pathogen in airway epithelial cells during the paroxysmal phase; late antibiotics fail to access intracellular bacteria, so cough duration is unchanged due to ongoing infection rather than prior epithelial damage.", "solution": "The problem statement is evaluated for validity before proceeding to a solution.\n\n### Step 1: Extract Givens\nThe problem provides the following information:\n- **Pathogen and Disease:** *Bordetella pertussis* causing whooping cough, characterized by paroxysmal cough.\n- **Fundamental Principles:**\n    - (i) Host cell repair (epithelial regeneration) is governed by the Central Dogma at finite rates.\n    - (ii) Antibiotics reduce bacterial numbers but do not reverse toxin modifications or regenerate tissue.\n    - (iii) Mucociliary clearance depends on functional ciliated cells.\n- **Pathogenesis:**\n    - Tracheal cytotoxin kills ciliated epithelial cells.\n    - Pertussis toxin and adenylate cyclase toxin cause sustained cellular dysfunction.\n    - Symptoms persist after bacterial decline due to toxin-mediated damage, until epithelial regeneration occurs.\n- **Quantitative Model:**\n    - Antibiotic therapy starts at time $t_a$ (late paroxysmal phase).\n    - Bacterial load for $t \\geq t_a$: $B(t) = B_0 e^{-k_{ab}(t - t_a)}$.\n    - Bacterial clearance rate constant: $k_{ab} = 1 \\ \\text{day}^{-1}$.\n    - Effective cilia density for $t \\geq t_d$: $D(t) = D_{\\infty} - \\left(D_{\\infty} - D_{\\min}\\right) e^{-r_e (t - t_d)}$.\n    - Epithelial regeneration rate constant: $r_e = 0.05 \\ \\text{day}^{-1}$.\n    - Minimum cilia density ratio: $D_{\\min}/D_{\\infty} = 0.3$.\n    - Symptom resolution threshold for cilia density: $D_{\\text{th}}/D_{\\infty} = 0.6$.\n- **Question:** Explain why initiating antibiotic therapy late in the paroxysmal phase has limited impact on the duration of cough.\n\n### Step 2: Validate Using Extracted Givens\n- **Scientifically Grounded:** The description of *Bordetella pertussis* pathogenesis, its toxins, and the resulting protracted cough due to epithelial damage is accurate and aligns with established medical microbiology. The use of a simplified mathematical model with exponential functions to describe population decay and tissue recovery is a standard and valid approach in systems biology. The parameters given reflect realistic biological timescales.\n- **Well-Posed:** The problem is well-posed. It provides a clear question and a self-contained set of biological premises and mathematical parameters sufficient to answer it. The question asks for an explanation based on the provided model, which allows for a unique, derivable conclusion.\n- **Objective:** The language is objective and clinical, free of subjective or ambiguous terminology.\n\n### Step 3: Verdict and Action\nThe problem statement is scientifically sound, logically consistent, and well-posed. It provides a valid basis for a rigorous analysis. The problem is **VALID**. We may proceed with the solution.\n\n### Derivation\nThe core of the problem is to compare the timescales of two distinct processes initiated or ongoing at the time of late antibiotic intervention ($t_a$): bacterial clearance and epithelial regeneration.\n\n1.  **Timescale of Bacterial Clearance:**\n    The bacterial load $B(t)$ is given by $B(t) = B_0 e^{-k_{ab}(t - t_a)}$ for $t \\geq t_a$. This is an exponential decay process. The characteristic time, or time constant, for this process is $\\tau_{ab} = 1/k_{ab}$.\n    Given $k_{ab} = 1 \\ \\text{day}^{-1}$, the time constant for bacterial clearance is:\n    $$\\tau_{ab} = \\frac{1}{1 \\ \\text{day}^{-1}} = 1 \\ \\text{day}$$\n    This signifies a rapid process. The bacterial population is reduced by a factor of $e^{-1} \\approx 0.37$ in just one day, and it becomes negligible (reduced by over $99\\%$) in a period of $5\\tau_{ab}$, or $5$ days.\n\n2.  **Timescale of Symptom Resolution (Epithelial Regeneration):**\n    Symptom resolution is tied to the recovery of mucociliary clearance, which occurs when the effective cilia density $D(t)$ reaches a threshold $D_{\\text{th}}$. The regeneration of cilia is described by $D(t) = D_{\\infty} - \\left(D_{\\infty} - D_{\\min}\\right) e^{-r_e (t - t_d)}$. This is an exponential recovery process towards the steady-state density $D_{\\infty}$. The characteristic time for this process is $\\tau_e = 1/r_e$.\n    Given $r_e = 0.05 \\ \\text{day}^{-1}$, the time constant for epithelial regeneration is:\n    $$\\tau_{e} = \\frac{1}{0.05 \\ \\text{day}^{-1}} = 20 \\ \\text{days}$$\n    This represents a much slower process compared to bacterial clearance.\n\n3.  **Comparison and Conclusion:**\n    The problem states that antibiotic therapy is initiated *late* in the paroxysmal phase. By this stage, significant toxin-mediated damage has already driven the cilia density down to its minimum, $D_{\\min}$. Therefore, the duration of the subsequent cough is determined by the time it takes for the epithelium to regenerate from $D_{\\min}$ to the functional threshold $D_{\\text{th}}$.\n\n    Let's calculate this recovery time, $\\Delta t_{\\text{recovery}} = t_{\\text{res}} - t_d$, where $t_{\\text{res}}$ is the time of resolution. We set $D(t_{\\text{res}}) = D_{\\text{th}}$:\n    $$D_{\\text{th}} = D_{\\infty} - (D_{\\infty} - D_{\\min}) e^{-r_e (t_{\\text{res}} - t_d)}$$\n    $$e^{-r_e (t_{\\text{res}} - t_d)} = \\frac{D_{\\infty} - D_{\\text{th}}}{D_{\\infty} - D_{\\min}}$$\n    Dividing the numerator and denominator by $D_{\\infty}$:\n    $$e^{-r_e (t_{\\text{res}} - t_d)} = \\frac{1 - D_{\\text{th}}/D_{\\infty}}{1 - D_{\\min}/D_{\\infty}}$$\n    Substituting the given ratios $D_{\\text{th}}/D_{\\infty} = 0.6$ and $D_{\\min}/D_{\\infty} = 0.3$:\n    $$e^{-r_e (t_{\\text{res}} - t_d)} = \\frac{1 - 0.6}{1 - 0.3} = \\frac{0.4}{0.7} = \\frac{4}{7}$$\n    Solving for the recovery duration:\n    $$\\Delta t_{\\text{recovery}} = t_{\\text{res}} - t_d = -\\frac{1}{r_e} \\ln\\left(\\frac{4}{7}\\right) = \\frac{1}{r_e} \\ln\\left(\\frac{7}{4}\\right)$$\n    $$\\Delta t_{\\text{recovery}} = (20 \\ \\text{days}) \\times \\ln(1.75) \\approx (20 \\ \\text{days}) \\times 0.5596 \\approx 11.2 \\ \\text{days}$$\n\n    The analysis shows a stark contrast in timescales: bacterial clearance operates on a characteristic time of $\\tau_{ab} = 1$ day, while epithelial regeneration operates on a characteristic time of $\\tau_e = 20$ days and requires over $11$ days to reach the functional threshold.\n\n    When antibiotics are given late, the damage is already done. The antibiotics rapidly eliminate the bacteria, preventing further toxin production, but they do not affect the already-damaged ciliated cells or the toxins already present. The patient's recovery from the cough is therefore dictated by the slow, intrinsic biological process of epithelial regeneration. The rate of this process, $r_e$, is the **rate-limiting step** for symptom resolution. Because this regeneration time is long and largely independent of the rapid bacterial clearance, the antibiotic therapy has a limited effect on shortening the overall duration of the established cough.\n\n### Option-by-Option Analysis\n\n**A. Once significant toxin-mediated epithelial damage has occurred, the rate-limiting step for symptom resolution is epithelial regeneration of ciliated cells, which proceeds on a timescale set by $r_e$ and is largely independent of how quickly antibiotics clear bacteria; therefore late antibiotic therapy minimally shortens cough duration.**\n-   **Analysis:** This statement accurately identifies epithelial regeneration as the rate-limiting step for recovery from an established cough. It correctly links this process to the parameter $r_e$ from the model and contrasts its slow timescale with the rapid action of antibiotics ($k_{ab}$). This explains why late therapy has limited impact on cough duration. This aligns perfectly with our derivation.\n-   **Verdict:** Correct.\n\n**B. Late antibiotic therapy prolongs cough because it inhibits development of protective immunological memory, delaying class-switching to immunoglobulin G in serum and thereby worsening mucociliary clearance independent of epithelial damage.**\n-   **Analysis:** This assertion is not supported by the problem statement. The provided model and biological premises attribute symptoms to epithelial damage, not immunological factors. The statement that therapy *prolongs* cough is counterintuitive and not part of the standard understanding or the given model. The claim that clearance is worsened \"independent of epithelial damage\" directly contradicts the model, where clearance is a function of cilia density $D(t)$.\n-   **Verdict:** Incorrect.\n\n**C. Antibiotics rapidly neutralize pertussis toxins in the airway, immediately reversing covalent modifications of host proteins and restoring ciliary function, so late therapy always substantially shortens cough duration.**\n-   **Analysis:** This statement fundamentally misrepresents the mechanism of antibiotics. As stated in \"Fundamental basis (ii),\" antibiotics act on bacteria, not on toxins. They do not reverse covalent modifications or magically regenerate tissue. This claim is factually incorrect based on both general pharmacology and the specific premises of the problem.\n-   **Verdict:** Incorrect.\n\n**D. *Bordetella pertussis* persists primarily as an intracellular pathogen in airway epithelial cells during the paroxysmal phase; late antibiotics fail to access intracellular bacteria, so cough duration is unchanged due to ongoing infection rather than prior epithelial damage.**\n-   **Analysis:** This option proposes an alternative mechanism (antibiotic failure due to intracellular reservoirs) that is explicitly contradicted by the provided model. The model equation $B(t) = B_0 e^{-k_{ab}(t - t_a)}$ with $k_{ab} = 1 \\ \\text{day}^{-1}$ describes an effective and rapid clearance of the bacterial population, not a failure to clear them. The model's explanation for prolonged cough is the persistence of damage, not the persistence of infection.\n-   **Verdict:** Incorrect.", "answer": "$$\\boxed{A}$$", "id": "4614436"}, {"introduction": "A positive PCR test for *Bordetella pertussis* seems definitive, but its true meaning depends heavily on the clinical context. This problem [@problem_id:4614445] guides you through the application of Bayes' theorem to explore how the pre-test probability of disease—the prevalence—dramatically alters the predictive value of a test. By calculating and comparing the Positive Predictive Value (PPV) in both a low-prevalence screening setting and a high-prevalence outbreak setting, you will develop a crucial skill in interpreting diagnostic data.", "problem": "A clinical microbiology laboratory is validating a nasopharyngeal Polymerase Chain Reaction (PCR) assay for Bordetella pertussis in two realistic practice settings. Use only the foundational probability definitions of sensitivity and specificity and Bayes’ theorem to reason from first principles.\n\nDefinitions to use:\n- Sensitivity is the conditional probability that the test is positive given true infection.\n- Specificity is the conditional probability that the test is negative given no infection.\n- Prevalence is the pre-test probability of infection in the tested population.\n- Positive Predictive Value (PPV) is the posterior probability of true infection given a positive test.\n- Negative Predictive Value (NPV) is the posterior probability of no infection given a negative test.\n\nAssume the PCR assay has sensitivity $0.90$ and specificity $0.99$. Consider two cohorts:\n- Community screening clinic with pertussis prevalence $0.01$.\n- Outbreak cohort with pertussis prevalence $0.10$.\n\nTasks:\n1. Using only the above definitions and Bayes’ theorem, compute the PPV and Negative Predictive Value (NPV) for each cohort. Express PPV and NPV as exact fractions where possible; do not round.\n2. To quantify how changes in prevalence alter the interpretability of a positive result, compute the ratio $R$ defined as the PPV in the outbreak cohort divided by the PPV in the community screening clinic. Report $R$ as a reduced exact fraction.\n\nProvide PPV and NPV in exact form as part of your working, but the final reported answer must be the single value of $R$ only. No units are required for any quantity in this problem. Do not use percentages; express probabilities as decimals or fractions.", "solution": "The problem statement is evaluated as valid. It is scientifically grounded in the principles of medical diagnostic testing and probability theory, well-posed with sufficient information for a unique solution, and objectively stated.\n\nLet us define the following events for a randomly selected individual from a given population:\n$D$: The event that the individual has a true infection with *Bordetella pertussis*.\n$D^c$: The event that the individual does not have a true infection.\n$T^+$: The event that the PCR assay result is positive.\n$T^-$: The event that the PCR assay result is negative.\n\nThe problem provides the following definitions and values, translated into the language of probability theory:\nPrevalence ($P_{\\text{prev}}$) is the prior probability of infection, $P(D)$.\nSensitivity (Sens) is the conditional probability of a positive test given infection, $P(T^+ | D)$.\nSpecificity (Spec) is the conditional probability of a negative test given no infection, $P(T^- | D^c)$.\nPositive Predictive Value (PPV) is the posterior probability of infection given a positive test, $P(D | T^+)$.\nNegative Predictive Value (NPV) is the posterior probability of no infection given a negative test, $P(D^c | T^-)$.\n\nThe given assay characteristics are:\nSensitivity, $\\text{Sens} = P(T^+ | D) = 0.90 = \\frac{9}{10}$.\nSpecificity, $\\text{Spec} = P(T^- | D^c) = 0.99 = \\frac{99}{100}$.\n\nFrom these, we can derive the probabilities of the complementary events:\nThe false negative rate is $P(T^- | D) = 1 - P(T^+ | D) = 1 - 0.90 = 0.10 = \\frac{1}{10}$.\nThe false positive rate is $P(T^+ | D^c) = 1 - P(T^- | D^c) = 1 - 0.99 = 0.01 = \\frac{1}{100}$.\n\nThe two cohorts have the following prevalences:\nCommunity screening clinic: $P_{\\text{prev,comm}} = P(D)_{\\text{comm}} = 0.01 = \\frac{1}{100}$.\nOutbreak cohort: $P_{\\text{prev,out}} = P(D)_{\\text{out}} = 0.10 = \\frac{1}{10}$.\n\nThe problem requires the computation of PPV and NPV for each cohort using Bayes' theorem.\n\nFirst, we derive the general formula for PPV, which is $P(D | T^+)$. According to Bayes' theorem:\n$$P(D | T^+) = \\frac{P(T^+ | D) P(D)}{P(T^+)}$$\nThe denominator, $P(T^+)$, is the total probability of a positive test, which can be expanded using the law of total probability:\n$$P(T^+) = P(T^+ | D) P(D) + P(T^+ | D^c) P(D^c)$$\nRecognizing that $P(D^c) = 1 - P(D)$ and substituting the defined terms, the formula for PPV becomes:\n$$\\text{PPV} = \\frac{(\\text{Sens})(P_{\\text{prev}})}{(\\text{Sens})(P_{\\text{prev}}) + (1 - \\text{Spec})(1 - P_{\\text{prev}})}$$\n\nSecond, we derive the general formula for NPV, which is $P(D^c | T^-)$. According to Bayes' theorem:\n$$P(D^c | T^-) = \\frac{P(T^- | D^c) P(D^c)}{P(T^-)}$$\nThe denominator, $P(T^-)$, is the total probability of a negative test, which can be expanded similarly:\n$$P(T^-) = P(T^- | D) P(D) + P(T^- | D^c) P(D^c)$$\nSubstituting the defined terms, the formula for NPV becomes:\n$$\\text{NPV} = \\frac{(\\text{Spec})(1 - P_{\\text{prev}})}{(1 - \\text{Sens})(P_{\\text{prev}}) + (\\text{Spec})(1 - P_{\\text{prev}})}$$\n\nNow, we apply these formulas to each cohort.\n\n**Task 1: Compute PPV and NPV for each cohort.**\n\n**Cohort 1: Community screening clinic**\nHere, $P_{\\text{prev}} = \\frac{1}{100}$, so $1 - P_{\\text{prev}} = \\frac{99}{100}$.\n\nThe Positive Predictive Value ($\\text{PPV}_{\\text{comm}}$) is:\n$$\\text{PPV}_{\\text{comm}} = \\frac{(\\frac{9}{10})(\\frac{1}{100})}{(\\frac{9}{10})(\\frac{1}{100}) + (\\frac{1}{100})(\\frac{99}{100})} = \\frac{\\frac{9}{1000}}{\\frac{9}{1000} + \\frac{99}{10000}} = \\frac{\\frac{90}{10000}}{\\frac{90}{10000} + \\frac{99}{10000}} = \\frac{90}{189}$$\nTo reduce the fraction, we divide the numerator and denominator by their greatest common divisor, which is $9$:\n$$\\text{PPV}_{\\text{comm}} = \\frac{90 \\div 9}{189 \\div 9} = \\frac{10}{21}$$\n\nThe Negative Predictive Value ($\\text{NPV}_{\\text{comm}}$) is:\n$$\\text{NPV}_{\\text{comm}} = \\frac{(\\frac{99}{100})(\\frac{99}{100})}{(\\frac{1}{10})(\\frac{1}{100}) + (\\frac{99}{100})(\\frac{99}{100})} = \\frac{\\frac{9801}{10000}}{\\frac{1}{1000} + \\frac{9801}{10000}} = \\frac{\\frac{9801}{10000}}{\\frac{10}{10000} + \\frac{9801}{10000}} = \\frac{9801}{9811}$$\nThis fraction is irreducible.\n\n**Cohort 2: Outbreak cohort**\nHere, $P_{\\text{prev}} = \\frac{1}{10}$, so $1 - P_{\\text{prev}} = \\frac{9}{10}$.\n\nThe Positive Predictive Value ($\\text{PPV}_{\\text{out}}$) is:\n$$\\text{PPV}_{\\text{out}} = \\frac{(\\frac{9}{10})(\\frac{1}{10})}{(\\frac{9}{10})(\\frac{1}{10}) + (\\frac{1}{100})(\\frac{9}{10})} = \\frac{\\frac{9}{100}}{\\frac{9}{100} + \\frac{9}{1000}} = \\frac{\\frac{90}{1000}}{\\frac{90}{1000} + \\frac{9}{1000}} = \\frac{90}{99}$$\nReducing the fraction by dividing by $9$:\n$$\\text{PPV}_{\\text{out}} = \\frac{90 \\div 9}{99 \\div 9} = \\frac{10}{11}$$\n\nThe Negative Predictive Value ($\\text{NPV}_{\\text{out}}$) is:\n$$\\text{NPV}_{\\text{out}} = \\frac{(\\frac{99}{100})(\\frac{9}{10})}{(\\frac{1}{10})(\\frac{1}{10}) + (\\frac{99}{100})(\\frac{9}{10})} = \\frac{\\frac{891}{1000}}{\\frac{1}{100} + \\frac{891}{1000}} = \\frac{\\frac{891}{1000}}{\\frac{10}{1000} + \\frac{891}{1000}} = \\frac{891}{901}$$\nThis fraction is irreducible as the prime factorization of the numerator is $3^4 \\times 11$ and the denominator is $17 \\times 53$.\n\n**Task 2: Compute the ratio R.**\nThe ratio $R$ is defined as the PPV in the outbreak cohort divided by the PPV in the community screening clinic.\n$$R = \\frac{\\text{PPV}_{\\text{out}}}{\\text{PPV}_{\\text{comm}}}$$\nSubstituting the calculated values:\n$$R = \\frac{\\frac{10}{11}}{\\frac{10}{21}} = \\frac{10}{11} \\times \\frac{21}{10} = \\frac{21}{11}$$\nThis result quantifies that a positive test is nearly twice as likely to represent a true infection in the outbreak setting compared to the community screening setting, demonstrating the profound impact of pre-test probability on the interpretation of diagnostic test results.", "answer": "$$\n\\boxed{\\frac{21}{11}}\n$$", "id": "4614445"}, {"introduction": "Controlling whooping cough at the population level relies on vaccination, but how do public health officials determine the necessary vaccination coverage? This practice [@problem_id:4614425] puts you in the role of an epidemiologist, using field data to calculate the basic reproduction number ($R_0$), a fundamental measure of transmissibility. You will then apply the concept of the herd immunity threshold to determine the minimum vaccination coverage required to prevent outbreaks, providing a clear link between epidemiological theory and public health practice.", "problem": "A case–contact investigation of Bordetella pertussis (whooping cough) in a university town measured the secondary attack rate (SAR) among unvaccinated, fully susceptible household contacts. Each identified close contact of an index case had an observed probability of becoming infected of $0.55$. Assume the following epidemiologically grounded simplifications are valid for this community during the period of infectiousness: (i) each index case has $14$ distinct close contacts, (ii) the per-contact transmission probability measured in households approximates the per-contact transmission probability for all close contacts of similar intensity, and (iii) transmission events to different contacts are independent.\n\nUsing the definition of the basic reproduction number ($R_0$) as the expected number of secondary infections generated by a single infectious individual in a fully susceptible population, first compute $R_0$ from these observations. Then, using the herd immunity threshold given by $H = 1 - \\frac{1}{R_0}$, and assuming the acellular pertussis vaccine (APV) behaves as a leaky vaccine with efficacy $E = 0.90$ in reducing transmission per vaccinated individual, derive the minimum vaccination coverage $p$ such that the effective reproduction number $R_e$ is less than $1$.\n\nExpress your final $p$ as a decimal (fraction of the population), and round your final answer to $4$ significant figures. Do not use a percent sign.", "solution": "The user has provided a problem in mathematical epidemiology. First, I will validate the problem statement.\n\n### Step 1: Extract Givens\n-   Observed probability of an unvaccinated, fully susceptible close contact becoming infected (secondary attack rate): $p_{inf} = 0.55$.\n-   Number of distinct close contacts per index case: $c = 14$.\n-   Assumption (i): Each index case has $14$ distinct close contacts.\n-   Assumption (ii): The per-contact transmission probability measured in households approximates the per-contact transmission probability for all close contacts of similar intensity.\n-   Assumption (iii): Transmission events to different contacts are independent.\n-   Definition of the basic reproduction number: $R_0$ is the expected number of secondary infections generated by a single infectious individual in a fully susceptible population.\n-   Formula for the herd immunity threshold: $H = 1 - \\frac{1}{R_0}$.\n-   Vaccine model: Acellular pertussis vaccine (APV) is a leaky vaccine.\n-   Vaccine efficacy in reducing transmission: $E = 0.90$.\n-   Objective: Find the minimum vaccination coverage $p$ such that the effective reproduction number $R_e$ is less than $1$.\n-   Required output format: A decimal rounded to $4$ significant figures.\n\n### Step 2: Validate Using Extracted Givens\nThe problem is scientifically grounded, using standard concepts from infectious disease epidemiology like secondary attack rate, basic and effective reproduction numbers, herd immunity, and leaky vaccine models. The provided numerical values ($p_{inf}=0.55$, $c=14$, $E=0.90$) are epidemiologically plausible for a highly transmissible respiratory pathogen like *Bordetella pertussis*. The problem is well-posed, objective, and self-contained, providing all necessary definitions, assumptions, and data to derive a unique solution. It does not violate any fundamental principles, is not based on false premises, and the language is precise.\n\n### Step 3: Verdict and Action\nThe problem is deemed valid. A solution will be derived.\n\n### Solution Derivation\nThe problem requires a multi-step calculation. We must first compute the basic reproduction number, $R_0$, then model the effective reproduction number, $R_e$, as a function of vaccination coverage $p$, and finally solve for the minimum value of $p$ that satisfies the condition $R_e < 1$.\n\n**1. Calculation of the Basic Reproduction Number ($R_0$)**\n\nThe basic reproduction number, $R_0$, is defined as the expected number of secondary infections produced by a single infectious individual in a completely susceptible population. Based on the problem statement, a single index case has $c = 14$ close contacts. The probability of transmission to any one of these susceptible contacts is the secondary attack rate, $p_{inf} = 0.55$. Since transmission events are independent, the total number of secondary infections follows a binomial distribution. The expected value is the product of the number of trials (contacts) and the probability of success (transmission) per trial.\n\n$$\nR_0 = c \\times p_{inf}\n$$\n\nSubstituting the given values:\n$$\nR_0 = 14 \\times 0.55 = 7.7\n$$\n\n**2. Modeling the Effective Reproduction Number ($R_e$)**\n\nThe effective reproduction number, $R_e$, is the average number of secondary infections in a population that is not fully susceptible due to vaccination. Let $p$ be the proportion of the population that is vaccinated. The vaccine is described as \"leaky\" with an efficacy $E=0.90$ in reducing transmission. This means that a vaccinated individual's probability of becoming infected upon contact is reduced by a factor of $E$.\n\nThe probability of transmission from an infectious individual to a randomly selected contact depends on the contact's vaccination status.\n-   The probability that a random contact is unvaccinated is $(1-p)$. The transmission probability for this contact is $p_{inf}$.\n-   The probability that a random contact is vaccinated is $p$. The transmission probability for this contact is reduced by the vaccine's efficacy, becoming $p_{inf} \\times (1-E)$.\n\nThe average probability of transmission, $\\bar{p}_{trans}$, to a randomly chosen contact in this mixed population is the weighted average:\n$$\n\\bar{p}_{trans} = (1-p) \\times p_{inf} + p \\times \\left[ p_{inf} \\times (1-E) \\right]\n$$\nWe can factor out $p_{inf}$:\n$$\n\\bar{p}_{trans} = p_{inf} \\left[ (1-p) + p(1-E) \\right] = p_{inf} [1 - p + p - pE] = p_{inf}(1 - pE)\n$$\nThe effective reproduction number $R_e$ is the product of the number of contacts $c$ and this average transmission probability $\\bar{p}_{trans}$:\n$$\nR_e = c \\times \\bar{p}_{trans} = c \\times p_{inf}(1 - pE)\n$$\nRecognizing that $R_0 = c \\times p_{inf}$, we can express $R_e$ in terms of $R_0$:\n$$\nR_e = R_0(1 - pE)\n$$\n\n**3. Determining the Minimum Vaccination Coverage ($p$)**\n\nTo control the epidemic and prevent sustained transmission, the effective reproduction number must be less than $1$.\n$$\nR_e < 1\n$$\nSubstituting our expression for $R_e$:\n$$\nR_0(1 - pE) < 1\n$$\nWe are looking for the minimum vaccination coverage $p$ that achieves this. This minimum value is found at the threshold where $R_e=1$.\n$$\nR_0(1 - pE) = 1\n$$\nWe now solve this equation for $p$.\n$$\n1 - pE = \\frac{1}{R_0}\n$$\n$$\npE = 1 - \\frac{1}{R_0}\n$$\n$$\np = \\frac{1}{E} \\left( 1 - \\frac{1}{R_0} \\right)\n$$\nThis formula gives the minimum required vaccination coverage. The term in the parenthesis, $1 - \\frac{1}{R_0}$, corresponds exactly to the herd immunity threshold $H$ mentioned in the problem.\n\n**4. Final Numerical Calculation**\n\nWe substitute the known values into the derived formula: $R_0 = 7.7$ and $E = 0.90$.\n$$\np = \\frac{1}{0.90} \\left( 1 - \\frac{1}{7.7} \\right)\n$$\n$$\np = \\frac{1}{0.90} \\left( \\frac{7.7 - 1}{7.7} \\right) = \\frac{1}{0.90} \\left( \\frac{6.7}{7.7} \\right)\n$$\n$$\np = \\frac{10}{9} \\times \\frac{6.7}{7.7} = \\frac{67}{9 \\times 7.7} = \\frac{67}{69.3}\n$$\n$$\np \\approx 0.9668109668...\n$$\nThe problem requires the answer to be rounded to $4$ significant figures. The fifth significant digit is $1$, so we round down.\n$$\np \\approx 0.9668\n$$\nThus, a minimum vaccination coverage of approximately $96.68\\%$ is required to ensure the effective reproduction number is less than $1$ under the given conditions.", "answer": "$$\\boxed{0.9668}$$", "id": "4614425"}]}